Funding for this research was provided by:
Canadian Institutes of Health Research (MOP-142233)
Received: 20 February 2020
Accepted: 5 May 2020
First Online: 15 May 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All patients enrolled in our P-PRRT trial (NCT02754297) and gave a written consent to participate. The institutional Ethics Committee (Comité d’éthique de la recherche CHU de Québec – Université Laval) approved the study.
: All authors read the manuscript and consented for its publication.
: The authors declare that they have no competing interests.